We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAMI
1076
Acadian Asset Management
AAMI
$3.19B
$268K 0.01%
18,000
PJT icon
1077
PJT Partners
PJT
$4.38B
$267K 0.01%
4,000
CYPH
1078
Cypherpunk Technologies Inc
CYPH
$73.3M
$263K 0.01%
29,830
NTWK icon
1079
NetSol Technologies
NTWK
$50.6M
$261K 0.01%
83,200
IOBT
1080
DELISTED
IO Biotech
IOBT
$260K 0.01%
95,900
+20,900
+28% +$77.5K
LBPH
1081
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$260K 0.01%
70,000
FEIM icon
1082
Frequency Electronics
FEIM
$816M
$259K 0.01%
45,000
MCBC
1083
DELISTED
Macatawa Bank Corp
MCBC
$259K 0.01%
28,000
CVR icon
1084
Chicago Rivet & Machine Co
CVR
$10.3M
$258K 0.01%
10,000
GROW icon
1085
US Global Investors
GROW
$38.5M
$258K 0.01%
89,753
+3,753
+4% +$14.6K
PRAX icon
1086
Praxis Precision Medicines
PRAX
$10.1B
$258K 0.01%
+7,573
New +$377K
CTMX icon
1087
CytomX Therapeutics
CTMX
$754M
$255K 0.01%
+176,000
New +$271K
TMO icon
1088
Thermo Fisher Scientific
TMO
$220B
$254K 0.01%
500
-4,500
-90% -$2.52M
FTH
1089
Faeth Therapeutics
FTH
$629M
$252K 0.01%
8,145
+6,250
+330% +$246K
FORM icon
1090
FormFactor
FORM
$9.17B
$251K 0.01%
10,000
ABBV icon
1091
AbbVie
ABBV
$435B
$249K 0.01%
1,859
ESPR
1092
DELISTED
Esperion Therapeutics
ESPR
$248K 0.01%
37,000
-70,000
-65% -$481K
TRVI icon
1093
Trevi Therapeutics
TRVI
$2.64B
$245K 0.01%
159,300
+56,700
+55% +$186K
PRLD icon
1094
Prelude Therapeutics
PRLD
$390M
$244K 0.01%
36,949
-10,000
-21% -$67.4K
ATLO icon
1095
AMES National
ATLO
$277M
$240K 0.01%
+10,808
New +$239K
CDZI icon
1096
Cadiz
CDZI
$291M
$239K 0.01%
125,900
+15,000
+14% +$50.5K
GTIM icon
1097
Good Times Restaurants
GTIM
$15.5M
$239K 0.01%
110,300
-8,300
-7% -$24.3K
AVYA
1098
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$239K 0.01%
+150,000
New +$238K
TFFP
1099
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$238K 0.01%
2,348
-832
-26% -$113K
CSSE
1100
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$238K 0.01%
34,646
+3,046
+10% +$28.2K

Similar funds

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.